Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.
The company today said it proposes offer for sale of $250 million of shares.
DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.
Source: Read Full Article
Lates News:
-
Cryptos Plunge Amidst Bad News, Bitcoin Drops To $25.4k
-
Cryptos Decline As Fuel Price Surge Renews Rate Hike Fears
-
Masonite To Buy PGT Innovations In $3 Bln Cash, Stock Deal
-
Jordan Peterson Sparks Discussion on Bitcoin vs. Traditional Banks
-
Helen Of Troy Q1 Results Down, But Beats Estimates; Backs FY24 Outlook; Stock Up In Premarket